UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Kinase Fusion Gene:CHUK_HPSE2 |
Kinase Fusion Protein Summary |
Kinase Fusion gene summary |
Kinase Fusion partner gene information | Kinase Fusion gene name: CHUK_HPSE2 | KinaseFusionDB ID: KFG1288 | FusionGDB2.0 ID: KFG1288 | Hgene | Tgene | Gene symbol | CHUK | HPSE2 | Gene ID | 1147 | 60495 | |
Gene name | component of inhibitor of nuclear factor kappa B kinase complex | heparanase 2 (inactive) | ||||||||||
Synonyms | BPS2|IKBKA|IKK-1|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16 | HPA2|HPR2|UFS|UFS1 | ||||||||||
Cytomap | 10q24.31 | 10q24.2 | ||||||||||
Type of gene | protein-coding | protein-coding | ||||||||||
Description | inhibitor of nuclear factor kappa-B kinase subunit alphaI-kappa-B kinase 1I-kappa-B kinase-alphaIKK-a kinaseIkB kinase alpha subunitNuclear factor NFkappaB inhibitor kinase alphaconserved helix-loop-helix ubiquitous kinasetranscription factor 16 | inactive heparanase-2heparanase 3heparanase-like protein | ||||||||||
Modification date | 20240407 | 20240403 | ||||||||||
UniProtAcc | O15111 | Q8WWQ2 | ||||||||||
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000370397, ENST00000590930, | ENST00000370546, ENST00000370549, ENST00000370552, ENST00000404542, | |||||||||
Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: CHUK [Title/Abstract] AND HPSE2 [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | CHUK(101979188)-HPSE2(100239866), # samples:1 |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CHUK | GO:0006468 | protein phosphorylation | 20434986 |
Hgene | CHUK | GO:0007249 | canonical NF-kappaB signal transduction | 9244310|9252186|9346484 |
Hgene | CHUK | GO:0034142 | toll-like receptor 4 signaling pathway | 26189595 |
Hgene | CHUK | GO:0038061 | non-canonical NF-kappaB signal transduction | 26189595 |
Hgene | CHUK | GO:0045944 | positive regulation of transcription by RNA polymerase II | 23091055 |
Hgene | CHUK | GO:0071356 | cellular response to tumor necrosis factor | 23091055 |
Kinase Fusion gene breakpoints across CHUK (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Kinase Fusion gene breakpoints across HPSE2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
Kinase Fusion gene information. |
Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
ChimerDB4 | TCGA-G9-6362-11A | CHUK | chr10 | 101979188 | HPSE2 | chr10 | 100239866 |
Top |
Kinase Fusion ORF Analysis |
Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
Top |
Kinase Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:101979188/:100239866) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CHUK | HPSE2 |
FUNCTION: Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:9244310, PubMed:9252186, PubMed:9346484, PubMed:18626576). Acts as a part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues (PubMed:9244310, PubMed:9252186, PubMed:9346484, PubMed:18626576, PubMed:35952808). These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome (PubMed:9244310, PubMed:9252186, PubMed:9346484, PubMed:18626576). In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis (PubMed:9244310, PubMed:9252186, PubMed:9346484, PubMed:18626576). Negatively regulates the pathway by phosphorylating the scaffold protein TAXBP1 and thus promoting the assembly of the A20/TNFAIP3 ubiquitin-editing complex (composed of A20/TNFAIP3, TAX1BP1, and the E3 ligases ITCH and RNF11) (PubMed:21765415). Therefore, CHUK plays a key role in the negative feedback of NF-kappa-B canonical signaling to limit inflammatory gene activation. As part of the non-canonical pathway of NF-kappa-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes (PubMed:20501937). In turn, these complexes regulate genes encoding molecules involved in B-cell survival and lymphoid organogenesis. Participates also in the negative feedback of the non-canonical NF-kappa-B signaling pathway by phosphorylating and destabilizing MAP3K14/NIK. Within the nucleus, phosphorylates CREBBP and consequently increases both its transcriptional and histone acetyltransferase activities (PubMed:17434128). Modulates chromatin accessibility at NF-kappa-B-responsive promoters by phosphorylating histones H3 at 'Ser-10' that are subsequently acetylated at 'Lys-14' by CREBBP (PubMed:12789342). Additionally, phosphorylates the CREBBP-interacting protein NCOA3. Also phosphorylates FOXO3 and may regulate this pro-apoptotic transcription factor (PubMed:15084260). Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). Phosphorylates AMBRA1 following mitophagy induction, promoting AMBRA1 interaction with ATG8 family proteins and its mitophagic activity (PubMed:30217973). {ECO:0000250|UniProtKB:Q60680, ECO:0000269|PubMed:12789342, ECO:0000269|PubMed:15084260, ECO:0000269|PubMed:17434128, ECO:0000269|PubMed:20434986, ECO:0000269|PubMed:20501937, ECO:0000269|PubMed:21765415, ECO:0000269|PubMed:30217973, ECO:0000269|PubMed:35952808, ECO:0000269|PubMed:9244310, ECO:0000269|PubMed:9252186, ECO:0000269|PubMed:9346484, ECO:0000303|PubMed:18626576}. | FUNCTION: Binds heparin and heparan sulfate with high affinity, but lacks heparanase activity. Inhibits HPSE, possibly by competing for its substrates (in vitro). {ECO:0000269|PubMed:20576607}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
- Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase-Substrate Information of CHUK_HPSE2 |
Phosphorylation target of the kinase (phosphosite, 03-17-2024) |
Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
CHUK | O15111 | human | NCOA3 | Q9Y6Q9 | S857 | PPYNRAVsLDsPVsV | |
CHUK | O15111 | human | MAP3K14 | Q99558 | S820 | PsKAsQSsRDTLSSG | |
CHUK | O15111 | human | NFKB1 | P19838 | S923 | DELRDSDsVCDsGVE | |
CHUK | O15111 | human | MTOR | P42345 | S1418 | AILEsLIsINNKLQQ | |
CHUK | O15111 | human | FOXA2 | Q9Y261 | S107 | AGMGPHLsPSLsPLG | Forkhead_N |
CHUK | O15111 | human | ATG16L1 | Q676U5 | S278 | PAGGLLDsITNIFGR | |
CHUK | O15111 | human | COPS5 | Q92905 | S201 | kPPDEGPsEyQtIPL | |
CHUK | O15111 | human | CTNNB1 | P35222 | S37 | yLDsGIHsGATtTAP | |
CHUK | O15111 | human | MTURN | Q8N3F0 | S58 | GDNFHVWsESEDCLP | DUF4581 |
CHUK | O15111 | human | H3C1 | P68431 | S10 | tkQtArkstGGkAPr | Histone |
CHUK | O15111 | human | CTNNB1 | P35222 | S45 | GATtTAPsLsGkGNP | |
CHUK | O15111 | human | CREBBP | Q92793 | S1382 | MkSRFVDsGEMsESF | HAT_KAT11 |
CHUK | O15111 | human | MTOR | P42345 | S1415 | PTPAILEsLIsINNK | |
CHUK | O15111 | human | RELA | Q04206 | S536 | sGDEDFSsIADMDFS | |
CHUK | O15111 | human | ELAVL1 | Q15717 | S304 | EAAMAIAsLNGYRLG | RRM_1 |
CHUK | O15111 | human | CCND1 | P24385 | T286 | EEVDLACtPtDVRDV | |
CHUK | O15111 | human | BCL3 | P20749 | S454 | PsPAPGGs_______ | |
CHUK | O15111 | human | FOXA2 | Q9Y261 | S111 | PHLsPSLsPLGGQAA | Forkhead_N |
CHUK | O15111 | human | NFKB2 | Q00653 | S870 | kEDsAyGsQsVEQEA | |
CHUK | O15111 | human | TAX1BP1 | Q86VP1-2 | S593 | NYKELKRsLENPAER | |
CHUK | O15111 | human | MYC | P01106 | S82 | PLsPsRRsGLCsPSy | Myc_N |
CHUK | O15111 | human | COPS5 | Q92905 | T205 | EGPsEyQtIPLNkIE | |
CHUK | O15111 | human | NFKBIA | P25963 | S32 | LLDDRHDsGLDsMkD | |
CHUK | O15111 | human | FOXO3 | O43524 | S644 | GLDFNFDsLISTQNV | FOXO-TAD |
CHUK | O15111 | human | REL | Q04864 | S557 | SNTTVFVsQSDAFEG | |
CHUK | O15111 | human | NFKB1 | P19838 | S927 | DSDsVCDsGVETsFR | |
CHUK | O15111 | human | MYC | P01106 | S86 | sRRsGLCsPSyVAVt | Myc_N |
CHUK | O15111 | human | ESR1 | P03372 | S118 | LHPPPQLsPFLQPHG | Oest_recep |
CHUK | O15111 | human | TRAF4 | Q9BUZ4 | S426 | kPGtWRGsLDEsSLG | |
CHUK | O15111 | human | NFKBIA | P25963 | S36 | RHDsGLDsMkDEEyE | |
CHUK | O15111 | human | NFKB2 | Q00653 | S872 | DsAyGsQsVEQEAEK | |
CHUK | O15111 | human | RELB | Q01201 | S472 | DFFSGTVsLPGLEPP | RelB_transactiv |
CHUK | O15111 | human | NFKB2 | Q00653 | S115 | sLVGkQCsELGICAV | RHD_DNA_bind |
CHUK | O15111 | human | AMBRA1 | Q9C0C7 | S1043 | CRPEALNsGVEYYWD | |
CHUK | O15111 | human | PPP1R1B | Q9UD71 | T34 | MIrRRRPtPAMLFRL | DARPP-32 |
CHUK | O15111 | human | MAP3K14 | Q99558 | S817 | EKNPsKAsQSsRDTL | |
CHUK | O15111 | human | NFKB2 | Q00653 | S99 | EVDLVtHsDPPRAHA | RHD_DNA_bind |
CHUK | O15111 | human | NCOR2 | Q9Y618 | S2407 | AkVSGRPsSRKAKsP | |
CHUK | O15111 | human | CTNNB1 | P35222 | S33 | QQQsyLDsGIHsGAT | |
CHUK | O15111 | human | BBC3 | Q9BXH1 | S10 | RARQEGSsPEPVEGL | PUMA |
CHUK | O15111 | human | MAP3K14 | Q99558 | S814 | DDSEKNPsKAsQSsR | |
CHUK | O15111 | human | CREBBP | Q92793 | S1386 | FVDsGEMsESFPyRT | HAT_KAT11 |
CHUK | O15111 | human | TAX1BP1 | Q86VP1-2 | S624 | RPPVRVPsWGLEDNV | |
CHUK | O15111 | human | NFKB2 | Q00653 | S123 | ELGICAVsVGPKDMT | RHD_DNA_bind |
CHUK | O15111 | human | CTNNB1 | P35222 | T41 | GIHsGATtTAPsLsG | |
CHUK | O15111 | human | NFKB1 | P19838 | S932 | CDsGVETsFRKLsFt | |
CHUK | O15111 | human | NFKB2 | Q00653 | S108 | PPRAHAHsLVGkQCs | RHD_DNA_bind |
CHUK | O15111 | human | NFKB2 | Q00653 | S866 | tAEVkEDsAyGsQsV |
Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
Enriched GO biological processes of the phosphorylation target genes of the kinase |
Kinase | GOID | GO term | P.adjust |
CHUK | ID | Description | 0.00e+00 |
CHUK | GO:0007249 | canonical NF-kappaB signal transduction | 3.57e-10 |
CHUK | GO:0038061 | non-canonical NF-kappaB signal transduction | 4.13e-10 |
CHUK | GO:2000628 | regulation of miRNA metabolic process | 1.35e-06 |
CHUK | GO:0140747 | regulation of ncRNA transcription | 1.35e-06 |
CHUK | GO:0051090 | regulation of DNA-binding transcription factor activity | 1.35e-06 |
CHUK | GO:0010586 | miRNA metabolic process | 2.26e-06 |
CHUK | GO:0098781 | ncRNA transcription | 9.17e-06 |
CHUK | GO:0035994 | response to muscle stretch | 9.28e-06 |
CHUK | GO:1902893 | regulation of miRNA transcription | 9.29e-06 |
CHUK | GO:0061614 | miRNA transcription | 9.29e-06 |
CHUK | GO:0043433 | negative regulation of DNA-binding transcription factor activity | 1.98e-05 |
CHUK | GO:0071496 | cellular response to external stimulus | 7.02e-05 |
CHUK | GO:0045637 | regulation of myeloid cell differentiation | 7.02e-05 |
CHUK | GO:1903706 | regulation of hemopoiesis | 2.14e-04 |
CHUK | GO:0043122 | regulation of canonical NF-kappaB signal transduction | 2.16e-04 |
CHUK | GO:2000630 | positive regulation of miRNA metabolic process | 2.16e-04 |
CHUK | GO:0030099 | myeloid cell differentiation | 2.16e-04 |
CHUK | GO:0009411 | response to UV | 2.31e-04 |
CHUK | GO:0048511 | rhythmic process | 3.25e-04 |
CHUK | GO:0030217 | T cell differentiation | 3.67e-04 |
CHUK | GO:1903131 | mononuclear cell differentiation | 3.67e-04 |
CHUK | GO:0009416 | response to light stimulus | 4.23e-04 |
CHUK | GO:1902894 | negative regulation of miRNA transcription | 4.43e-04 |
CHUK | GO:2000629 | negative regulation of miRNA metabolic process | 4.57e-04 |
CHUK | GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 4.57e-04 |
CHUK | GO:0071214 | cellular response to abiotic stimulus | 4.57e-04 |
CHUK | GO:0104004 | cellular response to environmental stimulus | 4.57e-04 |
CHUK | GO:0009612 | response to mechanical stimulus | 7.68e-04 |
CHUK | GO:0051403 | stress-activated MAPK cascade | 1.07e-03 |
CHUK | GO:0032355 | response to estradiol | 1.15e-03 |
CHUK | GO:0031098 | stress-activated protein kinase signaling cascade | 1.18e-03 |
CHUK | GO:0031669 | cellular response to nutrient levels | 1.48e-03 |
CHUK | GO:0009314 | response to radiation | 1.49e-03 |
CHUK | GO:0030098 | lymphocyte differentiation | 1.49e-03 |
CHUK | GO:0070741 | response to interleukin-6 | 1.64e-03 |
CHUK | GO:0048732 | gland development | 1.69e-03 |
CHUK | GO:0030879 | mammary gland development | 1.77e-03 |
CHUK | GO:0042088 | T-helper 1 type immune response | 1.97e-03 |
CHUK | GO:0031668 | cellular response to extracellular stimulus | 2.08e-03 |
CHUK | GO:1902895 | positive regulation of miRNA transcription | 2.38e-03 |
CHUK | GO:0031667 | response to nutrient levels | 2.75e-03 |
CHUK | GO:0034504 | protein localization to nucleus | 3.07e-03 |
CHUK | GO:0007254 | JNK cascade | 3.36e-03 |
CHUK | GO:1902105 | regulation of leukocyte differentiation | 3.43e-03 |
CHUK | GO:0022409 | positive regulation of cell-cell adhesion | 3.43e-03 |
CHUK | GO:0034250 | positive regulation of amide metabolic process | 3.61e-03 |
CHUK | GO:0033234 | negative regulation of protein sumoylation | 3.81e-03 |
CHUK | GO:0019827 | stem cell population maintenance | 4.71e-03 |
CHUK | GO:0032872 | regulation of stress-activated MAPK cascade | 4.91e-03 |
Top |
Related Drugs to CHUK_HPSE2 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Distribution of the number of studies mentioning CHUK-HPSE2 and kinase inhibitors the PubMed Abstract (04-01-2024) |
Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to CHUK_HPSE2 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
MeSH ID | MeSH term |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
Clinical Trials from clinicaltrials.gov (06-17-2024) |
Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |